GGTase-I β Antibodies

Santa Cruz Biotechnology delivers a wide array of GGTase-I β monoclonal antibodies for research focused on understanding this critical enzyme. GGTase-I β Antibodies are validated for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GGTase-I β, or geranylgeranyltransferase type I beta, is essential for the post-translational modification of proteins, particularly those involved in cell signaling and membrane dynamics. The enzyme plays a significant role in the prenylation of small GTPases, which are crucial for various cellular processes, including growth, differentiation, and apoptosis. Understanding GGTase-I β function is vital for elucidating its implications in cancer and other diseases where cell signaling pathways are disrupted. Research has shown that GGTase-I β activity influences numerous cellular pathways and regulatory mechanisms. Investigating GGTase-I β can reveal new therapeutic targets and treatment strategies for various diseases. Current studies continue to uncover novel roles of GGTase-I β in cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of GGTase-I β and its impact on human health.